series-c-plus
Stage
1
Investors
About
Avicanna is a commercial-stage biopharmaceutical company based in Toronto that develops, manufactures, and commercializes cannabinoid-based medical and pharmaceutical products. It operates an integrated platform covering active pharmaceutical ingredients, R&D and clinical development, a medical cannabis care platform, and proprietary finished products sold in multiple international markets.
Explore Avicanna's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.